lifestyle.newsblaze.com

Author: CDT Equity Inc.

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

April 16, 2026
CDT Notes Sarborg Publication of PRISM Framework Expanding AI

April 7, 2026
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

March 26, 2026
CDT Equity Inc. Announces Reverse Stock Split

March 25, 2026
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

March 23, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

March 18, 2026
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

March 12, 2026
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

March 5, 2026
CDT Positions for Transformational Growth

March 4, 2026
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

February 24, 2026